We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.88B
AUM Growth
+$618M
Cap. Flow
+$106M
Cap. Flow %
1.8%
Top 10 Hldgs %
22.46%
Holding
1,459
New
30
Increased
469
Reduced
96
Closed
51

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$9.68M
2
AMZN icon
Amazon
AMZN
+$6.71M
3
MSFT icon
Microsoft
MSFT
+$5.34M
4
META icon
Meta Platforms (Facebook)
META
+$3.18M
5
CRM icon
Salesforce
CRM
+$2.99M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17.5M
2
TFC icon
Truist Financial
TFC
+$8.4M
3
STI
SunTrust Banks, Inc.
STI
+$6.79M
4
DOC icon
Healthpeak Properties
DOC
+$4.82M
5
GEN icon
Gen Digital
GEN
+$2.93M

Sector Composition

Rank Sector Weight
1 Technology 23.11%
2 Financials 15.93%
3 Healthcare 15.67%
4 Consumer Discretionary 12.39%
5 Communication Services 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
76
Stryker
SYK
$130B
$14.7M 0.25%
70,124
-455
-0.6% -$94.4K
MS icon
77
Morgan Stanley
MS
$340B
$14.7M 0.25%
287,887
+9,480
+3% +$449K
INTU icon
78
Intuit
INTU
$89B
$14.7M 0.25%
56,151
-771
-1% -$202K
ISRG icon
79
Intuitive Surgical
ISRG
$134B
$14.4M 0.25%
73,197
-180
-0.2% -$33.7K
PNC icon
80
PNC Financial Services
PNC
$101B
$14.4M 0.25%
90,338
-934
-1% -$140K
CB icon
81
Chubb
CB
$135B
$14.3M 0.24%
91,748
+2,973
+3% +$455K
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$126B
$14M 0.24%
63,983
+204
+0.3% +$41.3K
BSX icon
83
Boston Scientific
BSX
$71.5B
$14M 0.24%
309,380
+17,490
+6% +$732K
TSLA icon
84
Tesla
TSLA
$1.3T
$13.9M 0.24%
499,155
+59,940
+14% +$1.3M
FISV
85
Fiserv Inc
FISV
$27.9B
$13.8M 0.24%
119,579
+1,637
+1% +$181K
ZTS icon
86
Zoetis
ZTS
$30.5B
$13.6M 0.23%
102,468
+1,911
+2% +$237K
BIIB icon
87
Biogen
BIIB
$30.7B
$13.5M 0.23%
45,595
-3,206
-7% -$890K
MU icon
88
Micron Technology
MU
$991B
$13.3M 0.23%
246,984
-3,713
-1% -$177K
CCI icon
89
Crown Castle
CCI
$32.2B
$13M 0.22%
91,244
+4,899
+6% +$668K
MRSH
90
Marsh
MRSH
$91.5B
$12.8M 0.22%
115,103
-4,931
-4% -$515K
AMAT icon
91
Applied Materials
AMAT
$428B
$12.8M 0.22%
209,220
-3,297
-2% -$185K
DE icon
92
Deere & Co
DE
$168B
$12.6M 0.21%
72,951
+3,286
+5% +$566K
SCHW
93
Charles Schwab
SCHW
$187B
$12.3M 0.21%
259,554
-2,879
-1% -$127K
CL icon
94
Colgate-Palmolive
CL
$74.4B
$12.2M 0.21%
176,927
-715
-0.4% -$48.7K
CSX icon
95
CSX Corp
CSX
$93.1B
$11.9M 0.2%
494,409
+4,128
+0.8% +$97.6K
HUM icon
96
Humana
HUM
$46.2B
$11.7M 0.2%
31,800
-2,013
-6% -$638K
NOW icon
97
ServiceNow
NOW
$129B
$11.6M 0.2%
204,835
-2,950
-1% -$155K
SHW icon
98
Sherwin-Williams
SHW
$89.8B
$11.4M 0.19%
58,722
+1,872
+3% +$357K
GPN icon
99
Global Payments
GPN
$22.8B
$11.4M 0.19%
62,346
+6,747
+12% +$1.16M
APD icon
100
Air Products & Chemicals
APD
$67.6B
$11.4M 0.19%
48,310
+4,848
+11% +$1.09M
2 3
4
5 6

Similar funds

HFA
Harvest Fund Advisors Wayne, Pennsylvania $4.87B AUM 49.03% 1-Year Est. Return
BPSG
Brookfield Public Securities Group New York $6.17B AUM
PIA
Piedmont Investment Advisors Durham, North Carolina $2.53B AUM 0.83% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
CEP
Chicago Equity Partners Chicago, Illinois $993M AUM 6.42% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return

Xact Kapitalforvaltning's Q4 2019 Portfolio in Review

As of Q4 2019, Xact Kapitalforvaltning held 1,459 positions worth $5.88B, up 12% from $5.26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Xact Kapitalforvaltning's Q4 2019 filing shows 30 new, 469 increased, 96 reduced and 51 closed positions. Its largest new stake was BeOne Medicines Ltd: 11,100 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Xact Kapitalforvaltning's largest Q4 2019 buy was BeOne Medicines Ltd: 11,100 shares worth $1.84M.
  • Xact Kapitalforvaltning added most to Alibaba in Q4 2019, an estimated $9.68M increase.
  • Xact Kapitalforvaltning's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.28M.
  • Xact Kapitalforvaltning fully exited Celgene Corp in Q4 2019, selling an estimated $17.5M.
  • Xact Kapitalforvaltning's ten largest holdings make up 22% of its $5.88B portfolio in Q4 2019.
  • Xact Kapitalforvaltning opened 30 new positions and closed 51 in Q4 2019.
  • Xact Kapitalforvaltning's portfolio value rose 12% quarter-over-quarter to $5.88B.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.